Steven Cohen Dia Medica Therapeutics Inc. Transaction History

Point72 Asset Management, L.P.

  • $36 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$4.45 - $9.91 $2.46 Million - $5.47 Million
-552,250 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$7.76 - $10.43 $1.92 Million - $2.58 Million
-247,750 Reduced 30.97%
552,250 $5.05 Million
Q3 2020

Nov 16, 2020
BUY
$3.91 - $7.15 $3.13 Million - $5.72 Million
800,000 New
800,000 $3.39 Million

Others Institutions Holding DMAC

# of Institutions
36
Shares Held
3.87M
Call Options Held
1.3K
Put Options Held
1K
View Full List

About DiaMedica Therapeutics Inc.

DMAC Quotes by TradingView
  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $116M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email